Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Susanne Baier"'
Autor:
Susanne Baier-Allen
Publikováno v:
Im Gespräch bleiben: Politische Wissenschaft und berufliche Praxis ISBN: 9783748926771
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd2c3a0a386f7b6539b6e13b8974c0e
https://doi.org/10.5771/9783748926771-689
https://doi.org/10.5771/9783748926771-689
Autor:
Paola Vanella, Orietta Dal Canton, Cinzia Ortega, Alessandra Gennari, Alfredo Berruti, Cosimo Sacco, Susanne Baier, Andrea R. Bellissimo, Elena Fea, Veronica Prati, Alessandro Comandone, Zuzana Sirotova, Consuelo Buttigliero, Francesca Valcamonico, Susanna Bianchi, Alberto Dalla Volta, Isabella Chiappino, Domenico Amoroso, Manuel Zamparini, Alessandra Mosca, Cristina Masini, Francesco Montagnani, Giovannino Ciccone, Marcello Tucci
Publikováno v:
European Journal of Cancer. 155:127-135
Background This study was designed to demonstrate the non-inferiority (NI) in overall survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and intermittent versus continuous docetaxel administration in metastatic castr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b72c4e3bed354d30f6aea8027b9148
https://doi.org/10.1016/j.ejca.2021.06.034
https://doi.org/10.1016/j.ejca.2021.06.034
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 18:1063-1066
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c75b26b56cfc0882ab91780571f7bec
https://doi.org/10.1111/ddg.14262_g
https://doi.org/10.1111/ddg.14262_g
Autor:
Laura Evangelista, Mariella Sorarù, Susanne Baier, Fable Zustovich, Francesca Maines, Marco Maruzzo, Maurizio Nicodemo, Lucia Fratino, Filippo Alongi, Rocco De Vivo, Vittorina Zagonel, Orazio Caffo, Umberto Basso, Andrea Zivi, Teodoro Sava, Eugenio Borsatti, Roberto Iacovelli, Dario Palleschi, Sara Galuppo
Publikováno v:
Clinical Genitourinary Cancer. 17:e187-e194
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64474f972cb2826d56c5648e6ef1a2d
https://doi.org/10.1016/j.clgc.2018.10.013
https://doi.org/10.1016/j.clgc.2018.10.013
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGReferences. 18(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0990ee965bda041fb041583a41d860b9
https://pubmed.ncbi.nlm.nih.gov/32909317
https://pubmed.ncbi.nlm.nih.gov/32909317
Autor:
Consuelo Buttigliero, Franco Morelli, Cristina Masini, Ilaria Zampiva, Ugo De Giorgi, Maria Giuseppa Vitale, Francesco Salaroli, V. Vanoni, Renzo Mazzarotto, Stefania Kinspergher, Cinzia Iotti, Sebastiano Buti, Franco Nolè, Alessio Bruni, Gabriele Carlinfante, Carmine Pinto, Claudia Mucciarini, Giuseppe Procopio, Susanne Baier, Roberto Salvatore Bellia
Publikováno v:
Journal of Clinical Oncology. 39:4558-4558
4558 Background: The NIVES study represents the first prospective trial with NIVO in combination with SBRT in pre-treated mRCC patients. This study did not meet the primary endpoint in terms of objective response rate (ORR) as previously reported. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::767e7d1258cc1ac65b445c7bb3a75189
https://doi.org/10.1200/jco.2021.39.15_suppl.4558
https://doi.org/10.1200/jco.2021.39.15_suppl.4558
Autor:
Alessio Bruni, Sebastiano Buti, Carmine Pinto, Stefania Kinspergher, Giuseppe Procopio, Franco Morelli, Roberto Salvatore Bellia, Cristina Masini, Cinzia Baldessari, Susanne Baier, Renzo Mazzarotto, Cinzia Iotti, Franco Nolè, Claudia Mucciarini, Ilaria Zampiva, Ugo De Giorgi, Consuelo Buttigliero, Francesco Salaroli, Annalisa Berselli
Publikováno v:
Web of Science
613 Background: NIVO showed an increased on OS in pre-treated mRCC. The introduction of metastasis SBRT could improve the clinical outcomes. NIVES Study evaluated the efficacy and safety of SBRT in combination with NIVO in II and III line of mRCC pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a86612d02722f12005048b8d85d7503
https://doi.org/10.1200/jco.2020.38.6_suppl.613
https://doi.org/10.1200/jco.2020.38.6_suppl.613
Autor:
Lena Schützler, Manfred Mitterer, Claudia M. Witt, Anton Wieser, Katja Icke, Arthur Scherer, Christian Thuile, Stephanie Roll, Oswald Mayr, Gilbert Spizzo, Herbert Heidegger, Susanne Baier, Oskar Außerer
Publikováno v:
Breast Cancer Research and Treatment. 149:449-460
The aim of this study was to evaluate the effectiveness of an additional, individualized, multi-component complementary medicine treatment offered to breast cancer patients at the Merano Hospital (South Tyrol) on health-related quality of life compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0581e80001694e2ba42da8d7285e78
https://doi.org/10.1007/s10549-014-3249-3
https://doi.org/10.1007/s10549-014-3249-3
Autor:
Ugo De Giorgi, Stefano Panni, Franco Morelli, Cristina Masini, Susanne Baier, Orazio Caffo, Carmelo Bengala, Cinzia Iotti, Sergio Bracarda, Maria Giuseppa Vitale, Sebastiano Buti, Franco Nolè, Roberto Iacovelli, Carmine Pinto, Patrizia Ciammella, Annalisa Berselli, Giuseppe Procopio, Giorgio V. Scagliotti, R. Gnoni, Claudia Mucciarini
Publikováno v:
Journal of Clinical Oncology. 36:TPS4602-TPS4602
TPS4602Background: Despite recent advances in drug therapy, pts with mRCC have about a 10% 5-year survival rate. Several preclinical studies have documented an increase in peripheral antitumour imm...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ebf705ba3dffba78eab865034779b55
https://doi.org/10.1200/jco.2018.36.15_suppl.tps4602
https://doi.org/10.1200/jco.2018.36.15_suppl.tps4602
Autor:
Stefano Severi, Vincenza Conteduca, Linda Valmorri, Ugo De Giorgi, Lucia Fratino, Emanuela Scarpi, Donatello Gasparro, Bernadette Vertogen, Cristina Masini, Giovanni Paganelli, Gaetano Facchini, Susanne Baier, Luca Galli, Sara Testoni, Stefania Gori, Valeria Sirna, Michele Aieta
Publikováno v:
Journal of Clinical Oncology. 36:TPS396-TPS396
TPS396 Background: Currently, the challenge is to reach a consensus on the best way to sequence different therapies for mCRPC patients (pts) in terms of efficacy and tolerability. Radium223 is a novel survival-prolonging targeted-α-therapy, but timi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cb559d417bd36368561837a9c8eb706
https://doi.org/10.1200/jco.2018.36.6_suppl.tps396
https://doi.org/10.1200/jco.2018.36.6_suppl.tps396